Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fortress Biotech (FBIO) Change in Acquisitions & Divestments (2017 - 2019)

Fortress Biotech (FBIO) has 3 years of Change in Acquisitions & Divestments data on record, last reported at $5.0 million in Q4 2019.

  • For Q4 2019, Change in Acquisitions & Divestments fell 50.0% year-over-year to $5.0 million; the TTM value through Dec 2020 reached $5.0 million, down 77.88%, while the annual FY2019 figure was $22.6 million, 68.16% down from the prior year.
  • Change in Acquisitions & Divestments reached $5.0 million in Q4 2019 per FBIO's latest filing, down from $5.0 million in the prior quarter.
  • Across five years, Change in Acquisitions & Divestments topped out at $25.0 million in Q3 2018 and bottomed at $5.0 million in Q4 2019.
  • Average Change in Acquisitions & Divestments over 3 years is $14.2 million, with a median of $12.3 million recorded in 2018.
  • The widest YoY moves for Change in Acquisitions & Divestments: up 47.67% in 2019, down 57.97% in 2019.
  • A 3-year view of Change in Acquisitions & Divestments shows it stood at $20.1 million in 2017, then tumbled by 50.22% to $10.0 million in 2018, then tumbled by 50.0% to $5.0 million in 2019.
  • Per Business Quant database, its latest 3 readings for Change in Acquisitions & Divestments were $5.0 million in Q4 2019, $5.0 million in Q2 2019, and $12.6 million in Q1 2019.